Mycoplasma iowae p45 antibody and antigen (recombinant protein)

Diagnostic anti-Mycoplasma iowae p45 antibodies pairs and antigen for animal health (animal Avian/Bird/Poultry infectious disease Avian Mycoplasmosis) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Avian/Bird/Poultry disease testing products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-VT-P189-Tg001-Ag01 Recombinant Mycoplasma iowae p45 protein $3090.00
GMP-VT-P189-Tg001-Ab01 Anti-Mycoplasma iowae p45 mouse monoclonal antibody (mAb) $3090.00
GMP-VT-P189-Tg001-Ab02 Anti-Mycoplasma iowae p45 mouse monoclonal antibody (mAb) $3090.00
GMP-VT-P189-Tg001-Ab03 Anti-Mycoplasma iowae p45 human monoclonal antibody (mAb) $3090.00
GMP-VT-P189-Tg001-Ab04 Anti-Mycoplasma iowae p45 human monoclonal antibody (mAb) $3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-VT-P189-Tg001-Ag01
Product Name Recombinant Mycoplasma iowae p45 protein
Pathogen Mycoplasma iowae
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Mycoplasma iowae p45 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Mycoplasma iowae level test of animal Avian/Bird/Poultry infectious disease with Avian Mycoplasmosis.
Tag His
Product description Recombinant Mycoplasma iowae p45 proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. GMP-VT-P189-Tg001-Ab01,GMP-VT-P189-Tg001-Ab02
Pathogen Mycoplasma iowae
Product Name Anti-Mycoplasma iowae p45 mouse monoclonal antibody (mAb)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Mycoplasma iowae p45 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Mycoplasma iowae antibodies in Mycoplasma iowae level test of animal Avian/Bird/Poultry infectious disease with Avian Mycoplasmosis.
Product description Anti-Mycoplasma iowae p45 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Mycoplasma iowae antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. GMP-VT-P189-Tg001-Ab03,GMP-VT-P189-Tg001-Ab04
Pathogen Mycoplasma iowae
Product Name Anti-Mycoplasma iowae p45 human monoclonal antibody (mAb)
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation Recombinant Mycoplasma iowae p45 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Mycoplasma iowae antibodies in Mycoplasma iowae level test of animal Avian/Bird/Poultry infectious disease with Avian Mycoplasmosis.
Product description Anti-Mycoplasma iowae p45 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Pathogen Information


    Pathogen Name and Classification:

    Mycoplasma iowae belongs to the Mollicutes class, which is distinct for its minimalistic cellular structure and genetic makeup. It lacks a cell wall, making it highly adaptable and capable of infecting various avian hosts, particularly chickens and turkeys.

    Pathogen Structure:

    The absence of a cell wall sets Mycoplasma iowae apart from many other bacteria. Despite its diminutive size, its genetic composition is intricate, housing genes crucial for adhesion to host cells and other biological functions necessary for infection and survival.

    Hosts and Diseases:

    Avian species, especially chickens and turkeys, are primary targets for Mycoplasma iowae. This pathogen is strongly associated with causing respiratory illnesses, notably infectious sinusitis in birds. Infected birds exhibit symptoms such as sneezing, nasal discharge, and respiratory distress. Moreover, the pathogen's impact extends to egg production in poultry, affecting the overall health and productivity of avian populations.

    Diagnostic Methods:

    Molecular Techniques: Polymerase chain reaction (PCR) assays serve as a primary diagnostic tool for identifying Mycoplasma iowae. These assays target specific genes or genetic markers unique to the pathogen, enabling accurate and rapid detection.

    Culturing Techniques: Laboratory culturing is employed to confirm the presence of the pathogen, providing additional evidence for diagnosis.

    Serological Tests: These tests focus on detecting antibodies produced by the host in response to the invasion of Mycoplasma iowae, aiding in the diagnosis process.

    Genomic Analysis: DNA sequencing and analysis of the pathogen's genome can provide in-depth insights into its genetic composition, evolution, and potential variations.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.